Abstract

IntroductionArsenic is a widely distributed environmental toxicant that can cause multi-tissue pathologies. Proteomic assays allow for the identification of biological processes modulated by arsenic in diverse tissue types.MethodThe altered abundance of proteins from HaCaT human keratinocyte cell line exposed to arsenic was quantified using a label-free LC-MS/MS mass spectrometry workflow. Selected proteomics results were validated using western blot and RT-PCR. A functional annotation analytics strategy that included visual analytical integration of heterogeneous data sets was developed to elucidate functional categories. The annotations integrated were mainly tissue localization, biological process and gene family.ResultThe abundance of 173 proteins was altered in keratinocytes exposed to arsenic; in which 96 proteins had increased abundance while 77 proteins had decreased abundance. These proteins were also classified into 69 Gene Ontology biological process terms. The increased abundance of transferrin receptor protein (TFRC) was validated and also annotated to participate in response to hypoxia. A total of 33 proteins (11 increased abundance and 22 decreased abundance) were associated with 18 metabolic process terms. The Glutamate--cysteine ligase catalytic subunit (GCLC), the only protein annotated with the term sulfur amino acid metabolism process, had increased abundance while succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial precursor (SDHB), a tumor suppressor, had decreased abundance.ConclusionA list of 173 differentially abundant proteins in response to arsenic trioxide was grouped using three major functional annotations covering tissue localization, biological process and protein families. A possible explanation for hyperpigmentation pathologies observed in arsenic toxicity is that arsenic exposure leads to increased iron uptake in the normally hypoxic human skin. The proteins mapped to metabolic process terms and differentially abundant are candidates for evaluating metabolic pathways perturbed by arsenicals.

Highlights

  • Arsenic is a widely distributed environmental toxicant that can cause multi-tissue pathologies

  • A possible explanation for hyperpigmentation pathologies observed in arsenic toxicity is that arsenic exposure leads to increased iron uptake in the normally hypoxic human skin

  • The proteins mapped to metabolic process terms and differentially abundant are candidates for evaluating metabolic pathways perturbed by arsenicals

Read more

Summary

Introduction

Arsenic is a widely distributed environmental toxicant that can cause multi-tissue pathologies. Arsenic (As) is a widely distributed environmental toxicant that causes skin cancer [1]. The types of skin cancer associated with arsenic include intraepidermal carcinomas (Bowen disease) [2], squamous cell carcinomas (SCC), basal cell carcinomas (BCC) [3], Merkel cell carcinoma (MCC) [4] and head and neck cancers [5]. Microarrays gene expression has revealed that arsenicals impact the function of diverse tissue types including the skin, [6,7], bladder and kidney [8], liver [9], prostate and lung [10], peripheral lymphocytes [11], neural tube [12], and urogenital cells [13]. New knowledge is needed to understand the molecular mechanisms of arsenic-induced cancers and arsenic-treatment of cancers in diverse tissue types

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call